Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers.

To examine the hypothesis that sildenafil, a phosphodiesterase type 5 inhibitor that inhibits cGMP breakdown, could enhance nitric oxide-mediated vasodilation and reverse endothelial dysfunction in chronic smokers.